A recent draft of the Trans-Pacific Partnership free-trade deal would give U.S. pharmaceutical firms unprecedented protections against competition from cheaper generic drugs, possibly transcending the patent protections in U.S. law. [Reposted from Politico  |  Michael Grunwald  |  July 1, 2015] POLITICO has obtained a draft copy of TPP’s intellectual property chapter as it stood on…